A. Hrõbjartsson

发表

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

E. Mayo-Wilson, J. Grimshaw, D. Moher, 2021, BMJ.

Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed.

A. Hrõbjartsson, D. Streiner, A. Donner, 2011, Journal of clinical epidemiology.

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

David Moher, Douglas G Altman, Peter C Gøtzsche, 2013, BMJ.

The Use of Placebo Interventions in Medical Practice—A National Questionnaire Survey of Danish Clinicians

A. Hrõbjartsson, M. Norup, 2003, Evaluation & the health professions.

Fertility after uterine artery embolization of fibroids: a systematic review

A. Hrõbjartsson, K. karlsen, M. Korsholm, 2017, Archives of Gynecology and Obstetrics.

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

A. Hrõbjartsson, D. Altman, P. Gøtzsche, 2004, JAMA.

SPIRIT 2013 statement: defining standard protocol items for clinical trials.

D. Rennie, A. Laupacis, D. Moher, 2013, Annals of internal medicine.

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

M. Hernán, P. Santaguida, P. Tugwell, 2016, British Medical Journal.

Ghost Authorship in Industry-Initiated Randomised Trials

Douglas G Altman, Peter C Gøtzsche, Asbjørn Hróbjartsson, 2007, PLoS medicine.

Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed.

David L Streiner, Byron J Gajewski, Allan Donner, 2011, International journal of nursing studies.

Benefits and harms of locking plate osteosynthesis in intraarticular (OTA Type C) fractures of the proximal humerus: a systematic review.

Lars Henrik Frich, Asbjørn Hróbjartsson, Stig Brorson, 2012, Injury.

Considering bias and conflicts of interest among the included studies

M. Page, I. Boutron, A. Hrõbjartsson, 2019, Cochrane Handbook for Systematic Reviews of Interventions.

The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration

David Moher, Douglas G Altman, Isabelle Boutron, 2013, Systematic Reviews.

Postponement of Death by Pharmacological Heart Failure Treatment: A Meta-Analysis of Randomized Clinical Trials.

A. Hrõbjartsson, J. Hallas, A. Pottegård, 2020, The American journal of medicine.

[Selective reporting of positive outcomes in randomised trials--secondary publication.. A comparison of protocols with published reports].

A. Hrõbjartsson, D. Altman, P. Gøtzsche, 2005, Ugeskrift for læger.

Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review

A. Hrõbjartsson, K. Jørgensen, L. Bero, 2020, BMJ.

Postponement of Death by Statin Use: a Systematic Review and Meta-analysis of Randomized Clinical Trials

A. Hrõbjartsson, J. Hallas, A. Pottegård, 2019, Journal of General Internal Medicine.

adherence to methodological or reporting quality

D. Moher, I. Boutron, A. Hrõbjartsson, 2017 .

Placebo interventions for all clinical conditions.

A. Hrõbjartsson, P. Gøtzsche, 2004, The Cochrane database of systematic reviews.

Placebo treatment versus no treatment.

A. Hrõbjartsson, P. Gøtzsche, P. C. Gøtzsche, 2002, The Cochrane database of systematic reviews.

Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.

A. Hrõbjartsson, K. Jørgensen, L. Bero, 2020, The Cochrane database of systematic reviews.

Interventions for the prevention and treatment of COVID-19: a living mapping of research and living network meta-analysis

I. Boutron, A. Hrõbjartsson, G. Grasselli, 2020, Cochrane Database of Systematic Reviews.

Interventions for the treatment of COVID-19: a living network meta-analysis

I. Boutron, A. Hrõbjartsson, G. Grasselli, 2020 .

Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors.

J. Hilden, I. Boutron, A. Hrõbjartsson, 2014, International journal of epidemiology.

Agreement was moderate between data-based and opinion-based assessments of biases affecting randomized trials within meta-analyses

I. Boutron, A. Hrõbjartsson, P. Whiting, 2020, Journal of clinical epidemiology.

Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates.

L. Trinquart, I. Boutron, A. Hrõbjartsson, 2016, The Cochrane database of systematic reviews.

Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory.

A. Hrõbjartsson, D. Altman, P. Gøtzsche, 2009, Journal of clinical epidemiology.

Randomized clinical trials with run-in periods: frequency, characteristics and reporting

A. Hrõbjartsson, D. L. T. Laursen, A. Paludan-Müller, 2019, Clinical epidemiology.

Unreported formal assessment of unblinding occurred in 4 of 10 randomized clinical trials, unreported loss of blinding in 1 of 10 trials.

A. Hrõbjartsson, S. Bello, Helene Moustgaard, 2017, Journal of clinical epidemiology.

Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020

A. Hrõbjartsson, M. Mearin, I. Korponay-Szabó, 2020 .

European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2019.

A. Hrõbjartsson, M. Mearin, I. Korponay-Szabó, 2020, Journal of pediatric gastroenterology and nutrition.

Active placebo versus standard placebo control interventions in pharmacological randomised trials

A. Hrõbjartsson, D. L. T. Laursen, A. Paludan-Müller, 2019 .

Letter re: stratification of meta-analyses based on risk of bias is appropriate and does not induce selection bias.

J. Sterne, M. Page, A. Hrõbjartsson, 2019, Journal of clinical epidemiology.

Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care.

A. Hrõbjartsson, K. Jørgensen, J. Jensen, 2014, The Cochrane database of systematic reviews.

Interleukin-1 blocking agents for treating COVID-19.

I. Boutron, A. Hrõbjartsson, G. Grasselli, 2022, The Cochrane database of systematic reviews.

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

E. Mayo-Wilson, J. Grimshaw, D. Moher, 2020, BMJ.

The COVID-NMA Project: Building an Evidence Ecosystem for the COVID-19 Pandemic

I. Boutron, A. Hrõbjartsson, G. Grasselli, 2020, Annals of Internal Medicine.

Syddansk Universitet Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials overview of published comments and analysis of user practice in Cochrane and non-Cochrane

J. Sterne, I. Boutron, A. Hrõbjartsson, 2016 .

Conflicts of interest and recommendations in clinical guidelines, opinion pieces, and narrative reviews

A. Hrõbjartsson, K. Jørgensen, L. Bero, 2019, Cochrane Database of Systematic Reviews.

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

E. Mayo-Wilson, J. Grimshaw, D. Moher, 2020, BMJ.

High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort.

A. Hrõbjartsson, H. Schmidt, L. Bastholt, 2019, European journal of cancer.

Assessing risk of bias in studies that evaluate health care interventions: recommendations in the misinformation age.

M. Page, I. Boutron, A. Hrõbjartsson, 2018, Journal of clinical epidemiology.

A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity.

David Moher, Douglas G Altman, Isabelle Boutron, 2016, Journal of clinical epidemiology.

What to do with a clinical trial with conflicts of interest

I. Boutron, A. Hrõbjartsson, L. Stewart, 2019, BMJ Evidence-Based Medicine.

A randomized trial comparing electronic and conventional stethoscopes.

A. Hrõbjartsson, L. Skovgaard, K. Iversen, 2005, The American journal of medicine.

Syddansk Universitet The matching quality of experimental and control interventions in blinded pharmacological randomised clinical trials

J. Hilden, A. Hrõbjartsson, S. Bello, 2016 .

Somatostatin analogues for acute bleeding oesophageal varices.

A. Hrõbjartsson, P. Gøtzsche, 2008, The Cochrane database of systematic reviews.

An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials

D. Moher, I. Boutron, A. Hrõbjartsson, 2022, Nature Network Boston.

Financial conflicts of interest in clinical research

E. Akl, A. Hrõbjartsson, J. Savović, 2018, Intensive Care Medicine.

Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors

J. Hilden, J. Hilden, I. Boutron, 2013, Canadian Medical Association Journal.

Why did it take 19 months to retrieve clinical trial data from a non-profit organisation?

A. Hrõbjartsson, 2013, BMJ.

Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors

Isabelle Boutron, Philippe Ravaud, Ann Sofia Skou Thomsen, 2012, BMJ : British Medical Journal.

Active placebo control groups of pharmacological interventions were rarely used but merited serious consideration: a methodological overview.

A. Hrõbjartsson, J. S. Jensen, A. Ø. Bielefeldt, 2017, Journal of clinical epidemiology.

Coding of adverse events of suicidality in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study

A. Hrõbjartsson, P. Gøtzsche, Andreas Lundh, 2014, BMJ : British Medical Journal.

Stratification of meta-analyses based on risk of bias is appropriate and does not induce selection bias. Journal of Clinical Epidemiology.

J. Sterne, M. Page, A. Hrõbjartsson, 2019 .

Performance of the Osteoporosis Self-Assessment Tool in ruling out low bone mineral density in postmenopausal women: a systematic review

A. Hrõbjartsson, L. Hyldstrup, B. Rud, 2007, Osteoporosis International.

Unreliable analysis of placebo analgesia in trials of placebo pain mechanisms

A. Hrõbjartsson, P. Gøtzsche, 2003, Pain.

Long-term Changes in Observed Behaviour after Exposure to Psychiatric Drugs A Systematic Review of Animal Studies

A. Hrõbjartsson, P. Gøtzsche, Anders Lykkemark Simonsen, 2017 .

Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study

J. Sterne, I. Boutron, A. Hrõbjartsson, 2020, BMJ.

Should doctors recommend acupuncture for pain?

A. Hrõbjartsson, E. Ernst, M. Cummings, 2018, British Medical Journal.

The Influence of Industry Funding and Other Financial Conflicts of Interest on the Outcomes and Quality of Systematic Reviews

A. Hrõbjartsson, P. Gøtzsche, Andreas Lundh, 2017 .

Effect of teaching and type of stethoscope on cardiac auscultatory performance.

A. Hrõbjartsson, L. Skovgaard, K. Iversen, 2006, American heart journal.

Were patients with unfavorable outcomes deleted in a covert duplicate publication reporting effect of placebo on hypertension?

A. Hrõbjartsson, P. Gøtzsche, 2006, American journal of hypertension.

Follow-up Commentary

A. Hrõbjartsson, P. Gøtzsche, 2006 .

Clinical Placebo Interventions Are Unethical, Unnecessary, and Unprofessional

A. Hrõbjartsson, 2008, The Journal of Clinical Ethics.

Efficacy and safety of COVID‐19 vaccines

I. Boutron, A. Hrõbjartsson, G. Grasselli, 2022, The Cochrane Database of Systematic Reviews.

Financial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological quality.

A. Hrõbjartsson, Andreas Lundh, Kristine Rasmussen, 2019, The Cochrane database of systematic reviews.

Non-surgical interventions for excessive anterior pelvic tilt in symptomatic and non-symptomatic adults: a systematic review

A. Hrõbjartsson, S. Overgaard, A. Holsgaard-Larsen, 2020, EFORT open reviews.

Danish University Colleges Nonsurgical interventions of excessive anterior pelvic tilt in symptomatic and non- symptomatic adults: a systematic review

A. Hrõbjartsson, S. Overgaard, A. Holsgaard-Larsen, 2020 .

Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups

A. Hrõbjartsson, P. Gøtzsche, M. V. Madsen, 2009, BMJ : British Medical Journal.

RoB 2: a revised tool for assessing risk of bias in randomised trials

Natalie S Blencowe, Christopher J Cates, Isabelle Boutron, 2019, BMJ.

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

E. Mayo-Wilson, J. Grimshaw, D. Moher, 2021, Systematic Reviews.

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

E. Mayo-Wilson, J. Grimshaw, D. Moher, 2021, PLoS medicine.

Training improves agreement among doctors using the Neer system for proximal humeral fractures in a systematic review.

A. Hrõbjartsson, S. Brorson, 2008, Journal of clinical epidemiology.

Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.

J. Hilden, A. Hrõbjartsson, D. Altman, 2007, International journal of epidemiology.

A revised tool for assessing risk of bias in randomized trials

Isabelle Boutron, Julian P T Higgins, Jonathan A C Sterne, 2016 .

The Osteoporosis Self-Assessment Tool versus alternative tests for selecting postmenopausal women for bone mineral density assessment: a comparative systematic review of accuracy

A. Hrõbjartsson, L. Hyldstrup, B. Rud, 2009, Osteoporosis International.

Performance of the Osteoporosis Self-Assessment Tool in ruling out low bone mineral density in postmenopausal women: a systematic review

J. Hilden, A. Hrõbjartsson, L. Hyldstrup, 2007, Osteoporosis International.

Control interventions in randomised trials among people with mental health disorders.

A. Hrõbjartsson, E. Simonsen, O. J. Storebø, 2022, The Cochrane database of systematic reviews.

Combining meta‐epidemiological study datasets on commercial funding of randomised clinical trials: Database, methods, and descriptive results of the COMFIT study

A. Hrõbjartsson, J. Savović, B. Olorisade, 2021, Research synthesis methods.

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.

E. Mayo-Wilson, J. Grimshaw, D. Moher, 2021, Journal of clinical epidemiology.

Minimum clinically important differences in chronic pain vary considerably by baseline pain and methodological factors: systematic review of empirical studies.

J. Hilden, A. Hrõbjartsson, M. Olsen, 2018, Journal of clinical epidemiology.

Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain

J. Hilden, A. Hrõbjartsson, M. Olsen, 2017, BMC Medicine.

Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment

A. Hrõbjartsson, P. Gøtzsche, A Hróbjartsson, 2004, Journal of internal medicine.

Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study

Andreas Lundh, Asbjørn Hróbjartsson, A. Hrõbjartsson, 2010, PLoS medicine.

Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis.

G. Rücker, G. Antes, A. Hrõbjartsson, 2013, JAMA internal medicine.

Placebo interventions for all clinical conditions.

Asbjørn Hróbjartsson, A. Hrõbjartsson, P. Gøtzsche, 2010, The Cochrane database of systematic reviews.

A systematic review found no consistent difference in effect between more and less intensive placebo interventions.

A. Hrõbjartsson, J. Kleijnen, K. Linde, 2015, Journal of clinical epidemiology.

University of Southern Denmark Systematic review adherence to methodological or reporting quality

Douglas G. Altman, David Moher, Isabelle Boutron, 2017 .

Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.

A. Hrõbjartsson, P. Gøtzsche, A Hróbjartsson, 2001, The New England journal of medicine.

Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.

A. Hrõbjartsson, S. Brorson, M. Haahr, 2007, International journal of epidemiology.

Locking plate osteosynthesis in displaced 4-part fractures of the proximal humerus

A. Hrõbjartsson, L. Frich, S. Brorson, 2011, Acta orthopaedica.

Improved interobserver variation after training of doctors in the Neer system. A randomised trial.

A. Hrõbjartsson, S. Brorson, J. Bagger, 2002, The Journal of bone and joint surgery. British volume.

Reverse shoulder arthroplasty in acute fractures of the proximal humerus: A systematic review

A. Hrõbjartsson, S. L. Jensen, L. Frich, 2013, International journal of shoulder surgery.

Effect of osteosynthesis, primary hemiarthroplasty, and non-surgical management for displaced four-part fractures of the proximal humerus in elderly: a multi-centre, randomised clinical trial

A. Hrõbjartsson, S. L. Jensen, L. Frich, 2009, Trials.

The methodological quality was low and conclusions discordant for meta-analyses comparing proximal humerus fracture treatments: a meta-epidemiological study.

A. Hrõbjartsson, S. Brorson, Ian A. Harris, 2021, Journal of clinical epidemiology.

Low agreement among 24 doctors using the Neer-classification; only moderate agreement on displacement, even between specialists

A. Hrõbjartsson, S. Brorson, J. Bagger, 2002, International Orthopaedics.

Diagnosing displaced four-part fractures of the proximal humerus: a review of observer studies

Stig Brorson, A. Hrõbjartsson, S. Brorson, 2009, International Orthopaedics.

Surgeons agree more on treatment recommendations than on classification of proximal humeral fractures

A. Hrõbjartsson, M. Krogsgaard, S. L. Jensen, 2012, BMC Musculoskeletal Disorders.

Resurfacing hemiarthroplasty compared to stemmed hemiarthroplasty for glenohumeral osteoarthritis: a randomised clinical trial

A. Hrõbjartsson, S. Brorson, B. Olsen, 2015, International Orthopaedics.

Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews

Isabelle Boutron, Jelena Savović, Jonathan A. C. Sterne, 2016, Systematic Reviews.

' s response to reviews Title : Spontaneous improvement in randomised clinical trials : meta-analysis of three-armed trials comparing no-treatment , placebo and active intervention

Peter C Gøtzsche, Asbjørn Hróbjartsson, A. Hrõbjartsson, 2008 .

The risk of unblinding was infrequently and incompletely reported in 300 randomized clinical trial publications.

A. Hrõbjartsson, S. Bello, Helene Moustgaard, 2014, Journal of clinical epidemiology.

Methods of Blinding in Reports of Randomized Controlled Trials Assessing Pharmacologic Treatments: A Systematic Review

D. Sackett, I. Boutron, A. Hrõbjartsson, 2006, PLoS medicine.

Systematic review finds that appraisal tools for medical research studies address conflicts of interest superficially.

I. Boutron, A. Hrõbjartsson, L. Stewart, 2019, Journal of clinical epidemiology.

Data extraction errors in meta-analyses that use standardized mean differences.

Peter C Gøtzsche, Asbjørn Hróbjartsson, Britta Tendal, 2007, JAMA.

Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies.

Ann Sofia Skou Thomsen, Asbjørn Hróbjartsson, Jørgen Hilden, 2014, International journal of epidemiology.

Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies

Jelena Savović, Jonathan A. C. Sterne, Julian P. T. Higgins, 2016, PloS one.

acupuncture groups acupuncture, placebo acupuncture, and no review of randomised clinical trials with Acupuncture treatment for pain: systematic

A. Hrõbjartsson, P. Gøtzsche, M. V. Madsen, 2009 .

Placebo effect studies are susceptible to response bias and to other types of biases.

A. Hrõbjartsson, T. Kaptchuk, F. Miller, 2011, Journal of clinical epidemiology.

The matching quality of experimental and control interventions in blinded pharmacological randomised clinical trials: a methodological systematic review

J. Hilden, A. Hrõbjartsson, S. Bello, 2016, BMC Medical Research Methodology.

Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study

A. Hrõbjartsson, D. Altman, P. Gøtzsche, 2005, BMJ : British Medical Journal.

Efficacy and safety of COVID‐19 vaccines

I. Boutron, A. Hrõbjartsson, G. Grasselli, 2022, The Cochrane database of systematic reviews.

SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

David Moher, Douglas G Altman, Peter C Gøtzsche, 2015, Revista panamericana de salud publica = Pan American journal of public health.

Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols

Douglas G Altman, Peter C Gøtzsche, Asbjørn Hróbjartsson, 2008, BMJ : British Medical Journal.

Placebo, usual care and wait-list interventions for all mental health disorders

A. Hrõbjartsson, E. Simonsen, C. Gluud, 2019, Cochrane Database of Systematic Reviews.

What are the main methodological problems in the estimation of placebo effects?

A. Hrõbjartsson, 2002, Journal of clinical epidemiology.

The uncontrollable placebo effect

A. Hrõbjartsson, 1996, European Journal of Clinical Pharmacology.

Lack of blinding of outcome assessors in animal model experiments implies risk of observer bias.

Asbjørn Hróbjartsson, A. Hrõbjartsson, Z. Zhao, 2014, Journal of clinical epidemiology.

Interleukin-6 blocking agents for treating COVID-19: a living systematic review.

I. Boutron, A. Hrõbjartsson, G. Grasselli, 2021, The Cochrane database of systematic reviews.

Impact of active placebo controls on estimated drug effects in randomised trials: a systematic review of trials with both active placebo and standard placebo.

A. Hrõbjartsson, M. R. Hansen, C. H. Nejstgaard, 2023, The Cochrane database of systematic reviews.

Blinding in Biomedical Research: An Essential Method to Reduce Risk of Bias

A. Hrõbjartsson, 2016 .

Blinding in Randomized Clinical Trials: Imposed Impartiality

I. Boutron, A. Hrõbjartsson, Isabelle Boutron, 2011, Clinical pharmacology and therapeutics.

Antibiotics for secondary prevention of coronary heart disease.

A. Hrõbjartsson, J. Jakobsen, C. Gluud, 2021, The Cochrane database of systematic reviews.

Antibiotics for secondary prevention of coronary heart disease

A. Hrõbjartsson, J. Jakobsen, C. Gluud, 2017 .

Postponement of cardiovascular outcomes by statin use: A systematic review and meta‐analysis of randomized clinical trials

A. Hrõbjartsson, J. Hallas, A. Pottegård, 2020, Basic & clinical pharmacology & toxicology.

The controlled clinical trial turns 100 years: Fibiger's trial of serum treatment of diphtheria

A. Hrõbjartsson, C. Gluud, Peter C G⊘tzsche, 1998, BMJ.

Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.

Rebecca J Williams, R. Emsley, D. Moher, 2021, JAMA.

Identifying approaches for assessing methodological and reporting quality of systematic reviews: a descriptive study

D. Moher, I. Boutron, A. Hrõbjartsson, 2017, Systematic Reviews.

Differential Effectiveness of Placebo Treatments

G. Rücker, G. Antes, A. Hrõbjartsson, 2014 .

Subjective and objective outcomes in randomized clinical trials: definitions differed in methods publications and were often absent from trial reports.

A. Hrõbjartsson, S. Bello, Helene Moustgaard, 2014, Journal of clinical epidemiology.

Promoting public access to clinical trial protocols: challenges and recommendations

A. Hrõbjartsson, A. Chan, 2018, Trials.

Syddansk Universitet Promoting public access to clinical trial protocols Challenges and recommendations

A. Hrõbjartsson, A. Chan, 2018 .

Reporting Methods of Blinding in Randomized Trials Assessing Nonpharmacological Treatments

David Moher, Isabelle Boutron, Philippe Ravaud, 2007, PLoS medicine.

Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors

Asbjørn Hróbjartsson, A. Hrõbjartsson, M. Haahr, 2006, Clinical trials.

Constraints on publication rights in industry-initiated clinical trials.

A. Hrõbjartsson, D. Altman, P. Gøtzsche, 2006, JAMA.

Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane

I. Boutron, A. Hrõbjartsson, K. Dwan, 2023, BMJ Evidence-Based Medicine.

Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials

Sihem Amer-Yahia, Emmanuel Coquery, Mohand-Said Hacid, 2020, Journal of Clinical Epidemiology.

Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications

A. Hrõbjartsson, P. Gøtzsche, K. Jørgensen, 2014, BMJ : British Medical Journal.

Influence and management of conflicts of interest in randomised clinical trials: qualitative interview study

I. Boutron, A. Hrõbjartsson, L. Stewart, 2020, BMJ.

Prevalence and prognosis of acutely ill patients with organ failure at arrival to hospital: A systematic review

A. Hrõbjartsson, A. Lassen, D. Henriksen, 2018, PloS one.

Prevalence and prognosis of acutely ill patients with organ failure at arrival to hospital: protocol for a systematic review

A. Hrõbjartsson, A. Lassen, D. Henriksen, 2017, Systematic Reviews.

Treatment effect sizes vary in randomized trials depending on type of outcome measure.

A. Hrõbjartsson, C. Juhl, M. Henriksen, 2020, Journal of clinical epidemiology.

Conflict of Interest Policies at Medical Schools and Teaching Hospitals: A Systematic Review of Cross-sectional Studies

A. Hrõbjartsson, Andreas Lundh, A. Fabbri, 2021, International journal of health policy and management.

Income from reprints creates a conflict of interests

Peter C Gøtzsche, Andreas Lundh, Asbjørn Hróbjartsson, 2012, BMJ : British Medical Journal.

Commercial funding and estimated intervention effects in randomized clinical trials: Systematic review of meta‐epidemiological studies

A. Hrõbjartsson, Andreas Lundh, C. H. Nejstgaard, 2022, Research synthesis methods.

Ten questions to consider when interpreting results of a meta‐epidemiological study—the MetaBLIND study as a case

J. Sterne, A. Hrõbjartsson, J. Higgins, 2019, Research synthesis methods.

Wampold et al.'s reiterate spin in the conclusion of a re‐analysis of placebo versus no‐treatment trials despite similar results as in original review

A. Hrõbjartsson, P. Gøtzsche, 2007 .

Powerful spin in the conclusion of Wampold et al.'s re-analysis of placebo versus no-treatment trials despite similar results as in original review.

Peter C Gøtzsche, Asbjørn Hróbjartsson, A. Hrõbjartsson, 2007, Journal of clinical psychology.

Unsubstantiated claims of large effects of placebo on pain: serious errors in meta-analysis of placebo analgesia mechanism studies.

Peter C Gøtzsche, Asbjørn Hróbjartsson, A. Hrõbjartsson, 2006, Journal of clinical epidemiology.

Response to Meissner: our preference of patient‐reported to observer‐reported outcomes has trivial influence on our updated systematic review of the effect of placebo

A. Hrõbjartsson, P. Gøtzsche, 2005 .

Interventions for preventing and treating COVID-19: protocol for a living mapping of research and a living systematic review

I. Boutron, A. Hrõbjartsson, P. Ravaud, 2020 .

Controversy and Debate on Meta-epidemiology. Paper 1: Treatment effect sizes vary in randomized trials depending on the type of outcome measure

A. Hrõbjartsson, C. Juhl, M. Henriksen, 2020 .

Response to Soares et al.

A. Hrõbjartsson, L. Bero, Q. Grundy, 2019, European Journal of Clinical Nutrition.

Placebo in Nonpharmacological Randomized Trials

A. Hrõbjartsson, F. Miller, 2011 .

Interleukin-6 blocking agents for treating COVID-19: a living systematic review.

I. Boutron, A. Hrõbjartsson, G. Grasselli, 2023, The Cochrane database of systematic reviews.

Divine intervention? A Cochrane review on intercessory prayer gone beyond science and reason

A. Hrõbjartsson, P. Gøtzsche, K. Jørgensen, 2009, Journal of Negative Results in BioMedicine.

Mechanisms and direction of allocation bias in randomised clinical trials

A. Hrõbjartsson, A. Paludan-Müller, David Ruben Teindl Laursen, 2016, BMC Medical Research Methodology.

Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study

A. Hrõbjartsson, P. Gøtzsche, J. Higgins, 2009, BMJ : British Medical Journal.

Meta-epidemiology and the MetaBLIND study: Response to Tack

A. Hrõbjartsson, Helene Moustgaard, 2023, Journal of health psychology.

Financial conflicts of interest and outcomes and quality of systematic reviews

A. Hrõbjartsson, P. Gøtzsche, Andreas Lundh, 2017 .

Somatostatin analogues for acute bleeding oesophageal varices.

A. Hrõbjartsson, P. Gøtzsche, 2005, Cochrane Database of Systematic Reviews.

Interventions for preventing and treating COVID-19: living systematic reviews and network meta-analyses

I. Boutron, A. Hrõbjartsson, G. Grasselli, 2020 .

Syddansk Universitet Mechanisms and direction of allocation bias in randomised clinical trials

A. Hrõbjartsson, Paludan-Müller, David Ruben Teindl, 2016 .

Spontaneous improvement in randomised clinical trials : meta-analysis of three-armed trials comparing no treatment , placebo and active intervention

A. Hrõbjartsson, P. Gøtzsche, Lasse T Krogsbøll, 2015 .

Effect of osteosynthesis, primary hemiarthroplasty, and non-surgical management for displaced four-part fractures of the proximal humerus in elderly: a multi-centre, randomised clinical trial.

A. Hrõbjartsson, S. L. Jensen, L. Frich, 2009, Trials.

Adherence to the PRISMA-P 2015 reporting guideline was inadequate in systematic review protocols.

A. Hrõbjartsson, C. H. Nejstgaard, Anders Dreyer Frost, 2022, Journal of Clinical Epidemiology.

Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates.

A. Hrõbjartsson, A. Yavchitz, Lee Aymar Ndounga Diakou, 2016, Cochrane Database of Systematic Reviews.

Prevalence and prognosis of acutely ill patients with organ failure at arrival to hospital: A systematic review

A. Hrõbjartsson, A. Lassen, D. Henriksen, 2018, PloS one.

Ghost Authorship in Industry-Initiated Randomised Trials

A. Hrõbjartsson, M. Haahr, P. Gøtzsche, 2007, PLoS medicine.

[Constraints on publication rights in industry-initiated clinical trials--secondary publication].

A. Hrõbjartsson, D. Altman, P. Gøtzsche, 2006, Ugeskrift for laeger.

Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups

A. Hrõbjartsson, P. Gøtzsche, M. V. Madsen, 2009, BMJ : British Medical Journal.

Efficacy and safety of COVID‐19 vaccines

I. Boutron, A. Hrõbjartsson, G. Grasselli, 2022, The Cochrane database of systematic reviews.

A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E).

Kyla W. Taylor, E. Akl, A. Hrõbjartsson, 2024, Environment international.

Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies.

Ann Sofia Skou Thomsen, J. Hilden, A. Hrõbjartsson, 2014, International journal of epidemiology.

Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study

A. Hrõbjartsson, Helene Moustgaard, D. L. T. Laursen, 2020, BMJ.

Transitivity, coherence, and reliability of network meta-analyses comparing proximal humerus fracture treatments: a meta-epidemiological study

A. Hrõbjartsson, S. Brorson, Nicolai Sandau, 2024, BMC musculoskeletal disorders.

Syddansk Universitet Prevalence and prognosis of acutely ill patients with organ failure at arrival to hospital protocol for a systematic review

A. Hrõbjartsson, A. Lassen, D. Henriksen, 2017 .

ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis

A. Hrõbjartsson, Erick H Turner, Andreas Lundh, 2023, BMJ.

Efficacy and safety of COVID‐19 vaccines

I. Boutron, A. Hrõbjartsson, G. Grasselli, 2022, The Cochrane database of systematic reviews.

a tool for assessing risk of bias in non-randomized studies

M. Hernán, P. Santaguida, J. Sterne, 2016 .

Subjective and objective outcomes in randomized clinical trials: definitions differed in methods publications and were often absent from trial reports.

A. Hrõbjartsson, S. Bello, Helene Moustgaard, 2014, Journal of clinical epidemiology.

Agreement was moderate between data-based and opinion-based assessments of biases affecting randomised trials within meta-analyses

A. Hrõbjartsson, J. Savovi, Jessica A. Haskins, 2020 .